Inclusion Criteria:~Participants meeting all of the following criteria will be included in this trial: 1) the
diagnostic criteria of Neurological Communicative Disorders and Stroke and the Alzheimer Disease and Related
Disorders Association (NINCDS-ADRDA) or the Operational Criteria for the Diagnosis of Alzheimer's disease
(OCDAD), 2) aged between 60-85 years, 3) cognitive impairment based on the scores of the Chinese version of the
Mini Mental State Examination (MMSE) (illiteracy group ≤19, primary school group ≤22, junior high school and
high school group ≤23, and well-educated group ≤26), 4) absence of depression (via an emotional assessment), 5)
Magnetic Resonance Imaging (MRI) confirmation of atrophy of the hippocampus or the medial temporal lobe volume,
6) the Medial Temporal Lobe Atrophy Rating Scale (MTA-scale) score (≥ 2 for those under 75 years, and ≥ 3 for
those over 75 years).~
